DFDA

Cyclosporine

Treatment for Interstitial Cystitis

Typical Dosage: 2.5-3.5 mg/kg/day

Effectiveness
70%
Safety Score
35%
Clinical Trials
1
Participants
500

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
35
DangerousModerateSafe
Treatment Details
Dosage Range
2.5-3.5 mg/kg/day
Time to Effect
1-3 months
Treatment Duration
6-12 months, or long-term if tolerated
Evidence Quality
MODERATE
Confidence Score
65%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$4,000
Monitoring:$2,400
Side Effect Mgmt:$1,000
Total Annual:$7,400
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
POOR
QALYs Gained
0.5
Outcome-Based Costs
Cost per Responder
$10,571.43
Cost per Remission
$49,333.33
Cyclosporine Outcomes

for Interstitial Cystitis

Efficacy Outcomes
Overall Effectiveness
+70%
Response Rate
+70%
Remission Rate
+15%
Common Side Effects
Nephrotoxicity
+15%
Hypertension
+15%
Headache
+12%
Gingival hyperplasia
+8%
Increased infection risk
+7%

Sources:

nih.gov
spandidos-publications.com
researchgate.net

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
No active trials currently recruiting for this treatment

No active trials found in ClinicalTrials.gov

Completed Clinical Trials
1 completed trial for Cyclosporine in Interstitial Cystitis

Cyclosporine in Interstitial Cystitis: Efficacy, Safety and Mechanism of Action

NCT01990898COMPLETEDPHASE2
View Study
26 participants
INTERVENTIONAL
Cleveland, United States
Started: Nov 1, 2013